Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 May;69(5):957–960. doi: 10.1038/bjc.1994.185

The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.

M S Aapro 1, V Kirchner 1, J P Terrey 1
PMCID: PMC1968891  PMID: 8180031

Abstract

Anticipatory nausea and vomiting (ANV) after repeated cycles of cytotoxic chemotherapy is thought to be a conditioned response to a conditioning stimulus. Good control of acute and delayed emesis may result in a lower incidence of ANV. We have analysed data from 574 chemotherapy patients who received granisetron as their antiemetic treatment during repeat cycle chemotherapy. Per treatment cycle, less than 10% of patients displayed symptoms of anticipatory nausea and 2% or less had symptoms of anticipatory vomiting. It is concluded that the use of granisetron as an antiemetic during the acute phase of chemotherapy may result in a lower incidence of ANV in patients undergoing repeat cycle chemotherapy.

Full text

PDF
957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrykowski M. A., Redd W. H., Hatfield A. K. Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol. 1985 Aug;53(4):447–454. doi: 10.1037//0022-006x.53.4.447. [DOI] [PubMed] [Google Scholar]
  2. Morrow G. R., Arseneau J. C., Asbury R. F., Bennett J. M., Boros L. Anticipatory nausea and vomiting with chemotherapy. N Engl J Med. 1982 Feb 18;306(7):431–432. doi: 10.1056/NEJM198202183060721. [DOI] [PubMed] [Google Scholar]
  3. Morrow G. R., Lindke J., Black P. M. Predicting development of anticipatory nausea in cancer patients: prospective examination of eight clinical characteristics. J Pain Symptom Manage. 1991 May;6(4):215–223. doi: 10.1016/0885-3924(91)90011-r. [DOI] [PubMed] [Google Scholar]
  4. Morrow G. R., Morrell C. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med. 1982 Dec 9;307(24):1476–1480. doi: 10.1056/NEJM198212093072402. [DOI] [PubMed] [Google Scholar]
  5. Nesse R. M., Carli T., Curtis G. C., Kleinman P. D. Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med. 1980 Jan;42(1):33–36. doi: 10.1097/00006842-198001000-00004. [DOI] [PubMed] [Google Scholar]
  6. Nicholas D. R. Prevalence of anticipatory nausea and emesis in cancer chemotherapy patients. J Behav Med. 1982 Dec;5(4):461–463. doi: 10.1007/BF00845373. [DOI] [PubMed] [Google Scholar]
  7. Redd W. H., Andresen G. V., Minagawa R. Y. Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. J Consult Clin Psychol. 1982 Feb;50(1):14–19. doi: 10.1037//0022-006x.50.1.14. [DOI] [PubMed] [Google Scholar]
  8. Wilcox P. M., Fetting J. H., Nettesheim K. M., Abeloff M. D. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep. 1982 Aug;66(8):1601–1604. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES